1. Home
  2. AQST vs FVR Comparison

AQST vs FVR Comparison

Compare AQST & FVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • FVR
  • Stock Information
  • Founded
  • AQST 2004
  • FVR 2016
  • Country
  • AQST United States
  • FVR United States
  • Employees
  • AQST N/A
  • FVR N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • FVR
  • Sector
  • AQST Health Care
  • FVR
  • Exchange
  • AQST Nasdaq
  • FVR NYSE
  • Market Cap
  • AQST 272.9M
  • FVR 227.7M
  • IPO Year
  • AQST 2018
  • FVR 2024
  • Fundamental
  • Price
  • AQST $4.06
  • FVR $12.50
  • Analyst Decision
  • AQST Strong Buy
  • FVR Hold
  • Analyst Count
  • AQST 7
  • FVR 5
  • Target Price
  • AQST $11.29
  • FVR $16.80
  • AVG Volume (30 Days)
  • AQST 1.3M
  • FVR 352.5K
  • Earning Date
  • AQST 08-05-2025
  • FVR 08-15-2025
  • Dividend Yield
  • AQST N/A
  • FVR 6.86%
  • EPS Growth
  • AQST N/A
  • FVR N/A
  • EPS
  • AQST N/A
  • FVR N/A
  • Revenue
  • AQST $54,228,000.00
  • FVR $60,901,000.00
  • Revenue This Year
  • AQST N/A
  • FVR $17.29
  • Revenue Next Year
  • AQST $45.71
  • FVR $8.41
  • P/E Ratio
  • AQST N/A
  • FVR N/A
  • Revenue Growth
  • AQST 5.29
  • FVR 15.85
  • 52 Week Low
  • AQST $2.12
  • FVR $10.61
  • 52 Week High
  • AQST $5.80
  • FVR $19.76
  • Technical
  • Relative Strength Index (RSI)
  • AQST 72.86
  • FVR N/A
  • Support Level
  • AQST $3.62
  • FVR N/A
  • Resistance Level
  • AQST $3.80
  • FVR N/A
  • Average True Range (ATR)
  • AQST 0.19
  • FVR 0.00
  • MACD
  • AQST 0.05
  • FVR 0.00
  • Stochastic Oscillator
  • AQST 95.43
  • FVR 0.00

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About FVR FRONTVIEW REIT INC

FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. The tenants of the company include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.

Share on Social Networks: